A detailed history of Limestone Investment Advisors LP transactions in Novo Nordisk A S stock. As of the latest transaction made, Limestone Investment Advisors LP holds 37,793 shares of NVO stock, worth $1.83 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
37,793
Previous 15,593 142.37%
Holding current value
$1.83 Million
Previous $1.08 Billion 94.86%
% of portfolio
0.17%
Previous 0.09%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$45.38 - $71.7 $1.01 Million - $1.59 Million
22,200 Added 142.37%
37,793 $2.1 Billion
Q2 2025

Aug 14, 2025

BUY
$58.08 - $81.05 $905,641 - $1.26 Million
15,593 New
15,593 $1.08 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Limestone Investment Advisors LP Portfolio

Follow Limestone Investment Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Limestone Investment Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Limestone Investment Advisors LP with notifications on news.